Interaction of [D-Ser2,Leu5]enkephalin-Thr6 (DSLET), a relatively selective delta ligand, with MU1 opioid binding sites

Yossef Itzhak, Gavril W. Pasternak

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Using binding approaches, we have confirmed the high selectivity of [D-Ser2,Leu5]enkephalin-Thr6 (DSLET) to delta, as opposed to morphine-preferring (mu2) sites in rat brain. However, detailed experiments studies indicate that this ligand also labels mu1 sites with very high affinity. Saturation studies of 3H-DSLET binding reveal curvilinear plots. Treating tissue with naloxonazine to block mu1 sites, eliminates the higher affinity binding component. Competition studies of the other peptites against 3H-DSLET and 3H[D-Ala2, MePhe4,Gly(ol)5] enkephalin (3H-DAMPGO) binding also implied high affinity binding of these peptides to mu1 sites. The ability of these peptides to interact with mu1 sites may help explain some of their pharmacological actions.

Original languageEnglish (US)
Pages (from-to)307-311
Number of pages5
JournalLife Sciences
Issue number3
StatePublished - Jan 19 1987

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)


Dive into the research topics of 'Interaction of [D-Ser<sup>2</sup>,Leu<sup>5</sup>]enkephalin-Thr<sup>6</sup> (DSLET), a relatively selective delta ligand, with MU<sub>1</sub> opioid binding sites'. Together they form a unique fingerprint.

Cite this